When was Imperial Innovations founded?

Imperial Innovations was founded in 1986.

Where is Imperial Innovations' headquarters located?

Imperial Innovations' headquarters is located in London (United Kingdom).

How many companies has Imperial Innovations invested in?

Imperial Innovations has invested in 100 companies, including Featurespace & Import.io.

Which companies has Imperial Innovations invested in lately?

Equinox Pharma & Enterprise Therapeutics are the latest investments by Imperial Innovations.

How many exits has Imperial Innovations been involved in?

Imperial Innovations' portfolio has seen 3 IPOs and 22 acquisitions.

Imperial Innovations - 2026 Investor Profile, Portfolio, Team & Investment Trends

Q: How big is Imperial Innovations' investment team?

Imperial Innovations has a team of 3.

1. Featurespace

Developer of risk management and fraud prevention software solutions. The company provides a platform designed to model and predict individual behavior in real time. This platform is used for fraud prevention and anti-money laundering purposes. It allows computers to understand when an individual customer’s behavior is out of character. The platform evaluates risk automatically.

Key facts about Featurespace

Founded Year: 2008
Location: Cambridge (United Kingdom)
Annual Revenue: £50M - £100M as on Dec 31, 2024
Last Known Valuation: $*****
Stage: Acquired
Total Funding till date: $111M
Employee Count: 283 as on May 31, 2026
Investors: Merian Global Investors, Highland Europe and 24 Others
Latest Funding Round: Grant (prize money), Nov 22, 2022, $*****
Highlight: Acquired

2. Import.io

Import.io's structure the web data and allows users to extract unstructured data from websites without writing any computer code. Users simply navigate to a website and teach the browser to extract data by showing it examples of where the data is, learning algorithms then generalize from these examples to work out how to get all the data on the website. The data that users collect is stored on import.io’s cloud servers to be downloaded and shared. Users can also generate an API from the data allowing them to easily integrate live web data into their own applications or third-party analytics and visualization software. The import.io data browser is free to download from the website. Clients include P&G, Amway and Accenture.

Key facts about Import.io

Founded Year: 2012
Location: London (United Kingdom)
Stage: Acquired
Total Funding till date: $38M
Employee Count: 82 as on Aug 31, 2026
Investors: AME Cloud Ventures, Wellington Partners Venture Capital and 28 Others
Latest Funding Round: Series B, Dec 18, 2018, $*****
Highlight: Acquired

3. Abingdon Health

Developer of immunoassays for diagnostic purposes. It offers a rapid lateral flow immunoassay system that enables multiplexed immunodiagnostics. Its flagship product Seralite- FLC measures kappa (K) and lambda (λ) immunoglobulin-free light chain used for the detection of hematological cancers. It als provide research services for a range of sectors including the clinical point of care, clinical self-test, pharmaceutical, and others.

Key facts about Abingdon Health

Founded Year: 2008
Location: York (United Kingdom)
Stage: Public
Total Funding till date: $24.1M
Employee Count: 96 as on Sep 30, 2026
Investors: IP Group, Mercia and 3 Others
Latest Funding Round: Post IPO, Oct 14, 2025, $*****
Highlight: Public

4. Mission Therapeutics

Developer of small molecule inhibitors targeting specific disease associated enzymes. These therapeutic candidates focus on the regulation of cellular quality control processes to address neurodegenerative conditions, heart disease, kidney disease, and fibrosis. The research centers on the modulation of protein degradation pathways to influence disease progression.

Key facts about Mission Therapeutics

Founded Year: 2011
Location: Cambridge (United Kingdom)
Annual Revenue: $1M - $10M as on Dec 31, 2016
Valuation: $*****
Stage: Series D
Total Funding till date: $192M
Employee Count: 11 - 50 as on Mar 01, 2026
Investors: Rosetta Capital, Roche Enterprises and 46 Others
Latest Funding Round: Series D, Oct 15, 2025, $*****
Highlight: Editors' Pick

5. Kymeta

Provider of flat panel antennas and connectivity services for various sectors. The company offers products suitable for military, government, maritime, and land applications. These products facilitate communications through satellite networks. The company also provides support, training, and resources related to its products and services.

Key facts about Kymeta

Founded Year: 2012
Location: Seattle (United States)
Stage: Series E
Total Funding till date: $559M
Employee Count: 222 as on Aug 31, 2026
Investors: Liberty Global, Hanwha and 12 Others
Latest Funding Round: Series E, Mar 15, 2022, $*****
Highlight: Editors' Pick

View the full list of portfolio companies

Imperial Innovations has invested in 100 companies over the last 20 years, with an average of 0 new investment annually in the last 10 years. Its most recent first time investment was in Equinox Pharma and most recent follow-on round was in Enterprise Therapeutics.

View all investments by Imperial Innovations

Imperial Innovations has made 26 investments in Series A stage with an average round size of $11.1M, 24 investments in Seed stage with an average round size of $2.44M and 3 investments in Series B stage with an average round size of $12.5M.

Here are Imperial Innovations' investments by stage:

Stage of entry	No. of Investments
Series A	26
Seed	24
Series B	3
PE	1
Series E	1
Others	1

Note: We have considered here, only first round of investments

View all investments by Imperial Innovations

Imperial Innovations has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, High Tech, Sustainability Tech and Consumer. Notably, it has invested in 79 Enterprise (B2B) companies, 76 Tech companies, 32 Software companies and at least 17 companies focusing on Tech hardware.

Here are Imperial Innovations' investments by sector:

Sector	No. of Investments
Life Sciences	25
Enterprise Applications	12
High Tech	10
Sustainability Tech	6
Consumer	5
Others	38

Note: We have considered here, only first round of investments

View all investments by Imperial Innovations

Imperial Innovations has made most investments in United Kingdom (49), followed by United States where it has made 4 investments.

Here are Imperial Innovations' investments by geography:

Country	No. of Investments
United Kingdom	49
United States	4
India	1
Japan	1

Note: We have considered here, only first round of investments

View all investments by Imperial Innovations

Imperial Innovations has not made any investment in 2026 so far.

Here are the most recent investments by Imperial Innovations:

Filter this list

Date	Company	Location	Round Details	Round Amount	Co-Investors
Jan 12, 2017	Equinox Pharma	United Kingdom	Seed	1073	-
Nov 10, 2016	Enterprise Therapeutics	United Kingdom	Series B	8160	Epidarex Capital
Sep 27, 2016	ThisWay Global	United Kingdom	Seed	8093	Grupa Pracuj [+1]
Sep 21, 2016	Artios	United Kingdom	Series A	1449	Arix Bioscience [+4]
Jul 19, 2016	Oxular	United Kingdom	Series A	8908	V-Bio Ventures [+3]

See more recent investments made by Imperial Innovations

3 of Imperial Innovations' portfolio companies have become public. Abingdon Health got listed on the London Stock Exchange (LSE), in Dec 2020 at marketcap of $130M and NIOX got listed on the London Stock Exchange (LSE).

Here are Imperial Innovations' portfolio companies that went public:

Filter this list

Company	IPO Date	First Invested on	First Round of Investment	Round Size
Abingdon Health	Dec 15, 2020	Mar 26, 2012	Series A	9365
NIOX	Mar 18, 2014	Jan 29, 2008	Series B	1141
IXICO	Oct 15, 2013	-	-	2772

View more details about public companies in Imperial Innovations' portfolio

22 companies from Imperial Innovations' portfolio have been acquired. The most recent acquisition was Import.io in Oct 2025 by Neuralogics for $*****.

Here are Imperial Innovations' portfolio companies that got acquired most recently:

Filter this list

Company	Acquisition Date	First Invested on	First Round of Investment	Round Size
Import.io	Oct 14, 2025	Jan 12, 2016	Series A	4746
Ieso Digital Health	Aug 20, 2025	Jan 11, 2013	Unattributed	9829
Oxular	Jan 02, 2025	Jul 19, 2016	Series A	9589
Featurespace	Sep 26, 2024	Jun 08, 2012	Seed	4199
Inflowmatix	Jun 22, 2021	Jul 28, 2015	Seed	5101

View all acquired companies in Imperial Innovations' portfolio

Imperial Innovations has a team of 3 members located in United Kingdom. Imperial Innovations' team does not sit on the board of any company as of now.

View team details of Imperial Innovations

Over the past 20 years, 376 investors have co-invested in Imperial Innovations's portfolio companies. This includes funds and angels.

Invested before Imperial Innovations: Wellington Partners Venture Capital, Michael Widenius and 34 others have invested in rounds before Imperial Innovations. There are 2 companies where Wellington Partners Venture Capital has invested before Imperial Innovations and 1 company where Michael Widenius has invested before Imperial Innovations.
Top Co-investors of Imperial Innovations: 84 investors entered a company along with Imperial Innovations. These include investors like SV Health Investors (4 companies).
Invested after Imperial Innovations: A total of 256 investors have invested in Imperial Innovations's portfolio after their investments. Top Investors include IP Group (15 companies) and Touchstone Innovations (12 companies).